Option Care Health (OPCH) Competitors

Option Care Health (NASDAQ:OPCH) and Amedisys (NASDAQ:AMED) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, community ranking, media sentiment, institutional ownership and profitability.

Is OPCH or AMED more profitable?

Amedisys has a net margin of 5.02% compared to Option Care Health's net margin of 3.94%. Amedisys' return on equity of 14.35% beat Option Care Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.94%	11.90%	5.19%
Amedisys	5.02%	14.35%	7.89%

Do institutionals and insiders hold more shares of OPCH or AMED?

97.6% of Option Care Health shares are owned by institutional investors. Comparatively, 96.2% of Amedisys shares are owned by institutional investors. 0.4% of Option Care Health shares are owned by company insiders. Comparatively, 2.1% of Amedisys shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the media refer more to OPCH or AMED?

In the previous week, Option Care Health had 4 more articles in the media than Amedisys. MarketBeat recorded 8 mentions for Option Care Health and 4 mentions for Amedisys. Option Care Health's average media sentiment score of 0.79 beat Amedisys' score of 0.54 indicating that Option Care Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Option Care Health	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amedisys	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in OPCH or AMED?

Amedisys received 411 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 57.58% of users gave Amedisys an outperform vote while only 56.94% of users gave Option Care Health an outperform vote.

Company	Underperform	Outperform
Option Care Health	Outperform Votes 41 56.94%	Underperform Votes 31 43.06%
Amedisys	Outperform Votes 452 57.58%	Underperform Votes 333 42.42%

Do analysts rate OPCH or AMED?

Option Care Health currently has a consensus target price of $37.88, suggesting a potential upside of 32.62%. Amedisys has a consensus target price of $108.94, suggesting a potential upside of 37.08%. Given Amedisys' higher possible upside, analysts plainly believe Amedisys is more favorable than Option Care Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Amedisys	2 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has better earnings and valuation, OPCH or AMED?

Option Care Health has higher revenue and earnings than Amedisys. Amedisys is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$3.94 billion	1.30	$150.56 million	$0.87	32.83
Amedisys	$2.23 billion	1.16	$118.61 million	$3.44	23.10

Which has more volatility and risk, OPCH or AMED?

Option Care Health has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

Summary

Option Care Health and Amedisys tied by winning 9 of the 18 factors compared between the two stocks.